Biological Properties of (1 → 3)-β- d -Glucan-Based Synthetic Oligosaccharides
- 1 April 2011
- journal article
- research article
- Published by SAGE Publications in Journal of Medicinal Food
- Vol. 14 (4) , 369-376
Abstract
Despite the fact that β-glucans are well-established immunomodulators, the problems with batch-to-batch heterogeneity remains problematic. The aim of this study was to prepare and evaluate new type of synthetic oligosaccharides. A new family of oligo-(1 → 3)-β- d -glucans modified on the reducing end was synthesized using a controlled and specific inversion of configuration at C-2 starting from already formed oligo-(1 → 3)-β- d -glucans. The designed glycosides are characterized by the presence of four or five glucopyranose entities and a mannose residue at the reducing end. To study of the impact of well-defined structural modulations, we used murine and human models to evaluate their immunostimulating potential. These novel oligosaccharides showed strong and long-lasting stimulation of phagocytosis and significant potentiation of synthesis and/or secretion of interleukin (IL-2, IL-4, IL-5, IL-6), tumor necrosis factor-α, and vascular endothelial growth factor. In addition, the oligosaccharides tested showed significant effects on expression of several genes in human fibroblasts and breast cancer cells. From our results it is clear that these synthetic oligosaccharides represent a better alternative to natural β-glucans.Keywords
This publication has 30 references indexed in Scilit:
- New oligo-β-(1,3)-glucan derivatives as immunostimulating agentsBioorganic & Medicinal Chemistry, 2010
- Role of p53, PUMA, and Bax in wogonin-induced apoptosis in human cancer cellsBiochemical Pharmacology, 2008
- Yeast-Derived β-Glucan Augments the Therapeutic Efficacy Mediated by Anti–Vascular Endothelial Growth Factor Monoclonal Antibody in Human Carcinoma Xenograft ModelsClinical Cancer Research, 2008
- Induction of p53 Up-Regulated Modulator of Apoptosis Messenger RNA by Chemotherapeutic Treatment of Locally Advanced Breast CancerClinical Cancer Research, 2005
- Identification of a Network Involved in Thapsigargin-induced Apoptosis Using a Library of Small Interfering RNA Expression Vectors*[boxs]Journal of Biological Chemistry, 2005
- Glucan-like synthetic oligosaccharides: iterative synthesis of linear oligo-β-(1,3)-glucans and immunostimulatory effectsGlycobiology, 2004
- Is NF-κB2/p100 a direct activator of programmed cell death?Cancer Cell, 2002
- NF-κB2 p100 is a pro-apoptotic protein with anti-oncogenic functionNature Cell Biology, 2002
- Keeping killers on a tight leash: transcriptional and post-translational control of the pro-apoptotic activity of BH3-only proteinsCell Death & Differentiation, 2002
- Effect of lentinan and mannan on phagocytosis of fluorescent latex microbeads by mouse peritoneal macrophages: A flow cytometric studyInternational Journal of Immunopharmacology, 1989